the effect of high power laser therapy on neuropathy induced by chemotherapy with taxane drugs in breast cancer patients

Phase 2

• Conditions: chemotherapy induced neuropathy.; Drug-induced polyneuropathy; G62.0

• Registration Number: IRCT20201203049585N3
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

diagnosed with breast cancer
Under chemotherapy with taxane drugs
Currently, the disease is under control.
Chemotherapy is over
A month has passed since the end of chemotherapy
she is suffering from chemotherapy induced neuropathy.

Exclusion Criteria

Metastatic breast cancer
Under multidrug chemotherapy
Before starting chemotherapy, have a history of neuropathy, such as diabetic neuropathy
Have a history of spinal canal stenosis and disk herniation.
Having diseases such as diabetes that can cause neuropathy complications.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
europathy score based on mTNS criteria. Timepoint: At the beginning of the study - at the end of the intervention - one month after the end of the intervention. Method of measurement: modified Total Neuropathy Score.;Neuropathy score based on CINQ questionnaire. Timepoint: At the beginning of the study - at the end of the intervention - one month after the end of the intervention. Method of measurement: chemotherapy-induced neurotoxicity questionnaire.